Matthew McNatt, Ph.D. is a scientific advisor in the New York office of Haug Partners. He was an entrepreneurial scientist who cofounded and was the Chief Science Officer of a fledgling biotech company. The company was focused on developing cell-lines to shorten the manufacturing timeline and to increase the titer of biologics with an emphasis on antibodies. As the Chief Science Officer, Dr. McNatt authored the patent to navigate around prior art and connected with advisors, collaborators and potential investors. Dr. McNatt leverages his business background to match the business needs of the client. Dr. McNatt earned his B.Sc. in Biochemistry from Michigan State University, a Ph.D. in Molecular and Cellular Biology from the University of Colorado, and a Postdoctoral Fellowship investigating HIV-1 at the Aaron Diamond Aids Research Center. He has special interest in the growing field of biologics and biosimilars where he can apply his 3+ years of litigation experience and his extensive 15+ years of research to evaluate the science and provide insightful counsel.
Poster Presentations (selected)